UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 502

Sortiert nach

Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non‐alcoholic fatty liver disease

Alimentary pharmacology & therapeutics, 2018-03, Vol.47 (5), p.631-644

2018

Volltextzugriff (PDF)

Systematic review with meta‐analysis: vasoactive drugs for the treatment of hepatorenal syndrome type 1

Alimentary pharmacology & therapeutics, 2017-03, Vol.45 (5), p.593-603

2017

Volltextzugriff (PDF)

Clinically significant chronic liver disease in people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study

QJM : An International Journal of Medicine, 2016-04, Vol.109 (4), p.249-256

2016

Volltextzugriff (PDF)

Systematic review with meta‐analysis: coffee consumption and the risk of cirrhosis

Alimentary pharmacology & therapeutics, 2016-03, Vol.43 (5), p.562-574

2016

Volltextzugriff (PDF)

Editorial: tackling hepatorenal syndrome—terlipressin for all, or time for a stratified approach?

Alimentary pharmacology & therapeutics, 2017-07, Vol.46 (2), p.193-194

2017

Volltextzugriff (PDF)

Editorial: getting bullish about portal hypertension—chronic treatment with oral taurine?

Alimentary pharmacology & therapeutics, 2018-02, Vol.47 (4), p.533-534

2018

Volltextzugriff (PDF)

Editorial: non‐invasive assessment of hepatic fibrosis in alpha‐1 antitrypsin deficiency using magnetic resonance elastography

Alimentary pharmacology & therapeutics, 2016-09, Vol.44 (6), p.644-645

2016

Volltextzugriff (PDF)

Editorial: measuring inflammatory and fibrotic components of portal hypertension – a noninvasive hepatic venous pressure gradient?

Alimentary pharmacology & therapeutics, 2016-07, Vol.44 (2), p.204-205

2016

Volltextzugriff (PDF)

Noninvasive Evaluation of Portal Hypertension: Emerging Tools and Techniques

International journal of hepatology (New York), 2012-01, Vol.2012, p.691089-7

2012

Volltextzugriff (PDF)

Editorial: spontaneous bacterial peritonitis – bacteriology, diagnosis, treatment, risk factors and prevention

Alimentary pharmacology & therapeutics, 2015-06, Vol.41 (12), p.1297-1297

2015

Volltextzugriff (PDF)

Reversal of liver fibrosis and cirrhosis--an emerging reality

Scottish medical journal, 2004-02, Vol.49 (1), p.3

2004

Volltextzugriff (PDF)

Remodelling of extracellular matrix is a requirement for the hepatic progenitor cell response

Gut, 2011-04, Vol.60 (4), p.525-533

2011

Volltextzugriff (PDF)

OC-064Hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study

Gut, 2012-07, Vol.61 (Suppl 2), p.A28-A28

2012

Volltextzugriff (PDF)

OC-064 Hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study

Gut, 2012-07, Vol.61 (Suppl 2), p.A28-A28

2012

Volltextzugriff (PDF)

PWE-146 Relaxin Is a Renal Vasodilator in Experimental Models of Cirrhosis and A Potential Novel Therapy for Hepatorenal Syndrome in Humans

Gut, 2013-06, Vol.62 (Suppl 1), p.A190-A191

2013

Volltextzugriff (PDF)

PWE-146RelaxinIs a Renal Vasodilator in Experimental Models of Cirrhosis and A Potential Novel Therapy for Hepatorenal Syndrome in Humans

Gut, 2013-06, Vol.62 (Suppl 1), p.A190-A191

2013

Volltextzugriff (PDF)

OC-031Relaxin Modulates Cirrhosis-induced Renal Vascular Endothelial Dysfunction

Gut, 2014-06, Vol.63 (Suppl 1), p.A16-A16

2014

Volltextzugriff (PDF)

OC-031 Relaxin Modulates Cirrhosis-induced Renal Vascular Endothelial Dysfunction

Gut, 2014-06, Vol.63 (Suppl 1), p.A16-A16

2014

Volltextzugriff (PDF)

Hepatic inflammation and fibrosis biomarkers are associated with cardiovascular risk factors but not cardiovascular disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study

The Lancet (British edition), 2013-02, Vol.381, p.S79-S79

2013

Volltextzugriff (PDF)

Targeted treatments for cirrhosis

Expert opinion on therapeutic targets, 2004-10, Vol.8 (5), p.423-435

2004

Volltextzugriff (PDF)

Endocrine and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer-Capivasertib-Fulvestrant: ASCO Rapid Recommendation Update

Journal of clinical oncology, 2024-04, Vol.42 (12), p.1450

2024

Volltextzugriff (PDF)

The role of matrix metalloproteinase-13 in the regression of liver fibrosis

Fallowfield, J A

2007

Volltextzugriff (PDF)

The ATAC adjuvant breast-cancer trial: Six-year results of the endometrial subprotocol

Journal of obstetrics and gynaecology, 2010-08, Vol.30 (6), p.596-604

2010

Volltextzugriff (PDF)

Quality of life assessment using patient-reported outcome (PRO) measures: still a Cinderella outcome?

Annals of oncology, 2018-12, Vol.29 (12), p.2286-2287

Fallowfield, L.J.

2018

Volltextzugriff (PDF)

Natural and surfactant modified zeolites: A review of their applications for water remediation with a focus on surfactant desorption and toxicity towards microorganisms

Journal of environmental management, 2018-01, Vol.205, p.253-261

2018

Volltextzugriff (PDF)

1 – 25 von 502

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(470)
Mit Volltextzugriff
(429)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of Oncology
(28)
Proceedings Of The Nutrition Society
(23)
Breast
(20)
Water Science And Technology
(20)
British Journal Of Cancer
(16)
European Journal Of Cancer
(15)
Cancer Research
(13)
Gut
(13)
Journal Of Clinical Oncology
(13)
Bmj
(12)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non‐alcoholic fatty liver disease

Systematic review with meta‐analysis: vasoactive drugs for the treatment of hepatorenal syndrome type 1

Clinically significant chronic liver disease in people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study

Systematic review with meta‐analysis: coffee consumption and the risk of cirrhosis

Editorial: tackling hepatorenal syndrome—terlipressin for all, or time for a stratified approach?

Editorial: getting bullish about portal hypertension—chronic treatment with oral taurine?

Editorial: non‐invasive assessment of hepatic fibrosis in alpha‐1 antitrypsin deficiency using magnetic resonance elastography

Editorial: measuring inflammatory and fibrotic components of portal hypertension – a noninvasive hepatic venous pressure gradient?

Noninvasive Evaluation of Portal Hypertension: Emerging Tools and Techniques

Editorial: spontaneous bacterial peritonitis – bacteriology, diagnosis, treatment, risk factors and prevention

Reversal of liver fibrosis and cirrhosis--an emerging reality

Remodelling of extracellular matrix is a requirement for the hepatic progenitor cell response

OC-064Hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study

OC-064 Hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study

PWE-146 Relaxin Is a Renal Vasodilator in Experimental Models of Cirrhosis and A Potential Novel Therapy for Hepatorenal Syndrome in Humans

PWE-146RelaxinIs a Renal Vasodilator in Experimental Models of Cirrhosis and A Potential Novel Therapy for Hepatorenal Syndrome in Humans

OC-031Relaxin Modulates Cirrhosis-induced Renal Vascular Endothelial Dysfunction

OC-031 Relaxin Modulates Cirrhosis-induced Renal Vascular Endothelial Dysfunction

Hepatic inflammation and fibrosis biomarkers are associated with cardiovascular risk factors but not cardiovascular disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study

Targeted treatments for cirrhosis

Endocrine and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer-Capivasertib-Fulvestrant: ASCO Rapid Recommendation Update

The role of matrix metalloproteinase-13 in the regression of liver fibrosis

The ATAC adjuvant breast-cancer trial: Six-year results of the endometrial subprotocol

Quality of life assessment using patient-reported outcome (PRO) measures: still a Cinderella outcome?

Natural and surfactant modified zeolites: A review of their applications for water remediation with a focus on surfactant desorption and toxicity towards microorganisms

Suchergebnisse filtern